Spinal astrocytes as therapeutic targets for pathological pain.
about
Neurological diseases and painChemokine-ligands/receptors: multiplayers in traumatic spinal cord injuryContributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicologyMolecular targeting of NOX4 for neuropathic pain after traumatic injury of the spinal cord.Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonal antibody to high mobility group box-1Persistent at-level thermal hyperalgesia and tactile allodynia accompany chronic neuronal and astrocyte activation in superficial dorsal horn following mouse cervical contusion spinal cord injuryProtection of Vascular Endothelial Growth Factor to Brain Edema Following Intracerebral Hemorrhage and Its Involved Mechanisms: Effect of Aquaporin-4MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis.Central administration of C-X-C chemokine receptor type 4 antagonist alleviates the development and maintenance of peripheral neuropathic pain in mice.Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injuryElectroacupuncture Confers Antinociceptive Effects via Inhibition of Glutamate Transporter Downregulation in Complete Freund's Adjuvant-Injected Rats.Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivitySpatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats.Role of astrocytes in pain.MicroRNAs are potential prognostic and therapeutic targets in diabetic osteoarthritis.Ligustilide Ameliorates Inflammatory Pain and Inhibits TLR4 Upregulation in Spinal Astrocytes Following Complete Freund's Adjuvant Peripheral Injection.Spinal astrocyte gap junction and glutamate transporter expression contributes to a rat model of bortezomib-induced peripheral neuropathy.Central α-adrenoceptors contribute to mustard oil-induced central sensitization in the rat medullary dorsal hornMinocycline markedly reduces acute visceral nociception via inhibiting neuronal ERK phosphorylation.The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states.Characterisation of pain responses in the high fat diet/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments.Downregulation of spinal astrocytic connexin43 leads to upregulation of interleukin-6 and cyclooxygenase-2 and mechanical hypersensitivity in mice.Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancer.Glial activation in the periaqueductal gray promotes descending facilitation of neuropathic pain through the p38 MAPK signaling pathway.8-O-Acetyl Shanzhiside Methylester From Lamiophlomis Rotata Reduces Neuropathic Pain by Inhibiting the ERK/TNF-α Pathway in Spinal Astrocytes.A β1/2 adrenergic receptor-sensitive intracellular signaling pathway modulates CCL2 production in cultured spinal astrocytes.Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush
P2860
Q26822891-89A03D8D-A522-4F3D-8746-D3238C526E6CQ27000469-66D28661-12CB-4D2D-9198-EF02F54B5005Q27005695-5366F4B5-44B6-42C3-BF4C-04EA5D34352AQ27863429-2901CEDD-933F-47F5-9F3C-58DB8734340CQ31133799-D5679A0C-3FC2-416A-A3D0-92060A7390DAQ34277397-9378DDDA-3AD9-4577-A427-C836F9DD59BCQ34785262-ECD5FBFD-E308-4D41-ABE3-C4E895B558F5Q34984847-23CCA5AE-0CE2-480B-AC1E-C5D71BFC7F54Q35224084-CCC7EE38-3EE2-482E-8D06-793AE2C019D2Q35296473-A16B8FA4-7D97-42FC-A56E-07EF12A097E4Q36204555-75952E66-A118-40C3-A01E-15FCFE50C29BQ36249124-ABF7CD29-23A2-40DE-A897-A2D669D1C8F6Q36348374-CB21853E-8342-45D2-80B0-8B70B06FB525Q36586687-7874EA2B-E695-42C8-A8FF-A384576F0A3BQ37950711-099735E7-8500-44D1-98BA-7A0246FDCC28Q38013662-467AB0D1-4BFB-4C4E-BFB1-5279814FA8B5Q38253187-DA6F4C64-7E7E-4E1A-9C4F-50EB0666AE0CQ40792862-E4DA1C65-3F33-49CD-B139-1805C58E13DEQ41759508-8CAF7154-708F-4232-A352-2368BC8298DCQ41867616-F0CA9FEE-D739-4E8D-85DD-20FDA688F6B9Q42145499-45A11E36-B432-4DE8-B4FD-1F72DDF924BCQ42161713-7909CCCC-FE8E-4D07-95A5-DC4E8923DC5FQ43159888-96093E41-5526-4CB1-951C-AAD533F0A3D5Q47438502-3FA1A4B9-243E-423A-8767-2BB203EC78C8Q47891073-9D93594B-1DD1-47FC-B629-F7CBE6285D6DQ52148661-5D89577B-1427-4739-A304-A004B41320B4Q52641643-EF7A5A7A-1804-4BEA-B935-8E59B17019FAQ54408970-B52F55B7-3337-4134-9F59-CF5AD0D43210Q58741796-ED9524BB-EB64-4E9C-ADAC-C0D46AE3AFC8
P2860
Spinal astrocytes as therapeutic targets for pathological pain.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Spinal astrocytes as therapeutic targets for pathological pain.
@ast
Spinal astrocytes as therapeutic targets for pathological pain.
@en
Spinal astrocytes as therapeutic targets for pathological pain.
@nl
type
label
Spinal astrocytes as therapeutic targets for pathological pain.
@ast
Spinal astrocytes as therapeutic targets for pathological pain.
@en
Spinal astrocytes as therapeutic targets for pathological pain.
@nl
prefLabel
Spinal astrocytes as therapeutic targets for pathological pain.
@ast
Spinal astrocytes as therapeutic targets for pathological pain.
@en
Spinal astrocytes as therapeutic targets for pathological pain.
@nl
P356
P1476
Spinal astrocytes as therapeutic targets for pathological pain.
@en
P2093
Takayuki Nakagawa
P304
P356
10.1254/JPHS.10R04CP
P50
P577
2010-11-11T00:00:00Z